Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharm Sin B 11 (2021) 420–433]
Pengzhao Shang,
Rui Gao,
Yijia Zhu,
Xiaorui Zhang,
Yang Wang,
Minji Guo,
Hui Peng,
Min Wang,
Juan Zhang
Affiliations
Pengzhao Shang
Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China
Rui Gao
Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China
Yijia Zhu
Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China
Xiaorui Zhang
Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China
Yang Wang
Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China
Minji Guo
Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China
Hui Peng
Department of Operational Medicine, Tianjin Institute of Environmental & Operational Medicine, Tianjin 300050, China
Min Wang
Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China
Juan Zhang
Antibody Engineering Laboratory, School of Life Science & Technology, China Pharmaceutical University, Nanjing 210009, China; Corresponding author.
